In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Biopharma Quarterly Dealmaking Statistics, Q1 2018

A look at financing, M&A and alliance activity January–March 2018

Executive Summary

Biopharma financing started the year solidly with $16.6 billion in total deal value, a 14% increase over the previous quarter. Q1 2018 biopharma merger and acquisition deal value, led by Cigna's $67 billion buy of Express Scripts, topped even the previous all-time-high set in Q4 2107, while alliances totaled $30.7 billion and featured big oncology and neurology partnerships.

Advertisement

Related Content

Billion Dollar Bets, Health Care Magic
BioNTech COO Sean Marett Reveals How To Spend $270M
GSK Gains Clarity For Pharma Focus Through Novartis Consumer JV Buy
GSK Exercises Right To Buy Out Novartis Consumer Healthcare JV For $13bn
GSK And Reckitt Opting Out Of Pfizer's Consumer Business Sale Speaks Volumes
Express Scripts Combination With Cigna's PBM Could Reverse Deficit From Losing Anthem
Cigna/Express Scripts: The End Of The Standalone PBM Era
Kolmar Korea Eyes Pharma Expansion Via CJ HealthCare Acquisition
Pfizer Mum On Consumer Business Plans As Analysts Say Spin-off
Celgene's $1.1bn Impact Buy Is First Of More Deals To Come In 2018 And Beyond

Topics

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV005330

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel